DI
Dr. Ignacio Anegon
Co-founder, Senior Consultant, and Member of the Scientific Advisory Board
AboleIIs PharmaTherapeutic Areas
AboleIIs Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ABO21009 | Rheumatoid Arthritis (RA) | Phase 1 |
Co-founder, Senior Consultant, and Member of the Scientific Advisory Board
AboleIIs Pharma| Drug | Indication | Phase |
|---|---|---|
| ABO21009 | Rheumatoid Arthritis (RA) | Phase 1 |